SkinHealth Systems SKIN Cash Flow Statement (2020-2026)

NASDAQ SKIN
$0.59 -0.01 (-0.87%)
At close: Aug 19, 2026 · 4:00 PM UTC
Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-215.15M-20.96M31.47M6.29M-0.10M6.56M-20.26M3.36M-73.82M-9.40M-0.64M0.25M-18.29M-10.37M-10.10M19.72M-11.04M-8.10M-6.63M-2.67M
Depreciation and Depletion (Quarter)
1.03M2.04M1.42M1.85M2.00M1.90M1.83M2.65M2.51M4.34M2.77M2.66M3.06M1.45M1.86M0.71M0.64M0.64M0.56M0.53M
Share-based Compensation (Quarter)
5.08M-8.62M0.93M2.19M9.91M8.19M-17.05M6.64M6.50M7.71M25.21M0.25M5.31M2.46M0.43M2.08M2.90M
Deferred Taxes (Quarter)
-1.86M1.57M0.03M-1.82M-0.28M0.28M0.33M-1.41M-1.03M-1.11M1.89M-3.50M-0.27M1.08M2.08M-0.67M-0.52M0.07M
Gains from Investment Securities (Quarter)
199.31M0.30M-52.05M-15.19M-4.28M-6.82M9.08M-11.59M-5.86M-3.56M1.46M-4.04M-0.42M-0.07M-0.35M0.21M-0.21M-0.14M
Asset Writedowns and Impairment (Quarter)
0.11M0.10M0.67M1.36M-0.36M3.47M3.34M1.03M18.80M-6.75M5.48M13.82M-14.17M-0.00M0.74M0.84M2.07M3.56M0.54M0.20M
Cash from Operations (Quarter)
0.30M3.28M-38.47M-31.34M-31.40M-5.39M-13.01M21.97M17.96M-5.17M-16.85M6.20M10.31M16.47M3.00M9.65M9.65M15.20M-5.55M2.67M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.33M-0.96M0.40M0.50M0.56M-1.46M
Amortization of Deferred Charges (Quarter)
3.35M1.06M1.10M1.10M1.06M1.06M1.06M1.06M1.06M0.95M0.80M0.79M0.79M0.79M0.85M0.98M1.01M1.01M0.99M
Depreciation & Amortization (CF) (Quarter)
1.03M2.04M1.42M1.85M2.00M1.90M1.83M2.65M2.51M4.34M2.77M2.66M3.06M1.45M1.86M0.71M0.64M0.64M0.56M0.53M
Change in Working Capital
Change in Receivables (Quarter)
-3.80M13.72M14.15M20.26M6.22M-8.61M-4.79M4.93M-6.14M-10.51M-5.88M-4.62M-2.85M-7.46M-3.99M1.71M-2.49M-0.39M-2.49M-0.88M
Change in Inventory (Quarter)
2.27M4.79M11.49M27.11M33.53M12.23M13.90M-11.30M-6.03M26.04M11.08M-4.51M0.90M3.03M-3.76M-5.33M-2.02M-4.68M0.14M-0.60M
Change in Account Payables (Quarter)
-5.68M18.57M-2.66M10.34M-0.62M-7.32M
Change in Accured Expenses (Quarter)
6.58M9.16M-6.64M15.09M-6.44M-4.97M-3.83M13.07M40.88M-6.12M-20.79M-17.90M-0.81M-4.28M-5.73M-3.99M2.60M-0.06M-9.56M12.66M
Change in Taxes (Quarter)
1.42M-2.39M3.91M-1.68M-1.39M-0.17M
Other Working Capital Changes (Quarter)
0.45M3.06M-1.29M6.50M1.51M7.12M1.32M10.86M4.01M-9.25M-1.94M-4.33M-1.69M-7.52M-2.91M2.34M0.68M-3.53M-0.03M17.67M
Investing Activities
Capital Expenditures (Quarter)
-0.93M10.69M3.15M2.43M4.30M0.97M2.32M1.30M0.17M0.03M0.34M0.33M0.00M0.07M0.04M0.09M0.03M0.14M0.22M0.43M
Acquisitions (Quarter)
17.98M-6.86M
Cash from Investing Activities (Quarter)
-20.08M-8.53M-3.42M-4.88M-7.74M-2.82M-21.68M-3.22M-4.44M-2.17M-1.80M-2.04M-2.09M-0.86M-1.15M-1.55M-1.08M-1.38M-1.65M-1.21M
Financing Activities
Other financing activities (Quarter)
-0.73M-169.42M-0.23M-0.36M-0.30M
Cash from Financing Activities (Quarter)
637.78M188.21M-0.78M-1.98M-100.00M-102.48M-2.19M-1.55M-2.35M-31.36M-58.62M-98.75M-0.20M-0.77M-0.25M-173.36M-0.80M-0.51M-20.91M-0.22M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
Additional items
Exchange Rate Effect (Quarter)
-0.84M0.30M0.03M-0.07M2.38M-5.32M0.97M0.24M-1.46M2.28M-1.12M-0.50M1.33M-3.67M1.37M4.24M-0.36M-0.03M-0.21M0.47M
Change in Cash (Quarter)
617.99M182.96M-42.68M-38.19M-139.14M-110.70M-36.89M17.20M11.18M-38.70M-77.27M-94.59M8.02M14.84M1.60M-165.27M7.76M13.30M-28.11M1.24M
Free Cash Flow (Quarter)
1.23M-7.41M-41.62M-33.76M-35.70M-6.36M-15.33M20.66M17.79M-5.20M-17.20M5.87M10.31M16.40M2.95M9.55M9.62M15.06M-5.78M2.24M
Net Cash Flow (Quarter)
617.99M182.96M-42.68M-38.19M-139.14M-110.70M-36.89M17.20M11.18M-38.70M-77.27M-94.59M8.02M14.84M1.60M-165.27M7.76M13.30M-28.11M1.24M